tetano
Editor, Senior Moderator
Microb Pathog
. 2021 Jul 26;105108.
doi: 10.1016/j.micpath.2021.105108. Online ahead of print.
Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro
Fuxiao Liu[SUP] 1 [/SUP], Jiahui Lin[SUP] 2 [/SUP], Qianqian Wang[SUP] 2 [/SUP], Hu Shan[SUP] 3 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19), as an unprecedented pandemic, has rapidly spread around the globe. Its etiological agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belongs to the genus Betacoronavirus in the family Coronaviridae. The viral S1 subunit has been demonstrated to have a powerful potential in inducing protective immune responses in vivo. Since April 2020, farmed minks were frequently reported to be infected with the SARS-CoV-2 in different countries. Unfortunately, there has been no available veterinary vaccine as yet. In this study, we used reverse genetics to rescue a recombinant canine distemper virus (CDV) that could express the SARS-CoV-2 S1 subunit in vitro. The S1 subunit sequence was demonstrated to be relatively stable in the genome of recombinant CDV during twenty serial viral passages in cells. However, due to introduction of the S1 subunit sequence into CDV genome, this recombinant CDV grew more slowly than the wild-type strain did. The genomic backbone of recombinant CDV was derived from a virulence-attenuating strain (QN strain). Therefore, if able to induce immune protections in minks from canine distemper and COVID-19 infections, this recombinant would be a potential vaccine candidate for veterinary use.
Keywords: Canine distemper virus; Recombinant virus; Reverse genetics; S1 subunit; SARS-CoV-2; Vaccine candidate.
. 2021 Jul 26;105108.
doi: 10.1016/j.micpath.2021.105108. Online ahead of print.
Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro
Fuxiao Liu[SUP] 1 [/SUP], Jiahui Lin[SUP] 2 [/SUP], Qianqian Wang[SUP] 2 [/SUP], Hu Shan[SUP] 3 [/SUP]
Affiliations
- PMID: 34324997
- DOI: 10.1016/j.micpath.2021.105108
Abstract
The coronavirus disease 2019 (COVID-19), as an unprecedented pandemic, has rapidly spread around the globe. Its etiological agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belongs to the genus Betacoronavirus in the family Coronaviridae. The viral S1 subunit has been demonstrated to have a powerful potential in inducing protective immune responses in vivo. Since April 2020, farmed minks were frequently reported to be infected with the SARS-CoV-2 in different countries. Unfortunately, there has been no available veterinary vaccine as yet. In this study, we used reverse genetics to rescue a recombinant canine distemper virus (CDV) that could express the SARS-CoV-2 S1 subunit in vitro. The S1 subunit sequence was demonstrated to be relatively stable in the genome of recombinant CDV during twenty serial viral passages in cells. However, due to introduction of the S1 subunit sequence into CDV genome, this recombinant CDV grew more slowly than the wild-type strain did. The genomic backbone of recombinant CDV was derived from a virulence-attenuating strain (QN strain). Therefore, if able to induce immune protections in minks from canine distemper and COVID-19 infections, this recombinant would be a potential vaccine candidate for veterinary use.
Keywords: Canine distemper virus; Recombinant virus; Reverse genetics; S1 subunit; SARS-CoV-2; Vaccine candidate.